Delving into the Latest Updates on FIBREX Medical, Inc. with Synapse

A Multicenter, Double Blind, Randomized, Placebo Controlled Study to Measure the Effect of FX06 (a Fibrin Derived Peptide Bbeta15-42) on Ischemia Reperfusion Injury in Patients Undergoing Primary Percutaneous Coronary Intervention (PCI): The "F.I.R.E." Study

The purpose of the study is to evaluate whether FX06 is capable of limiting infarct size following balloon catheterization for acute myocardial infarction.

开始日期2006-08-01

申办/合作机构

FIBREX Medical, Inc.

EUCTR2006-000619-51-DE / Not yet recruitingN/A

A Multicenter, Double-blind, Randomized, Placebo-Controlled Study to Measure the Effect of FX06 (a fibrin derived peptide Bß15-42) on Ischemia-Reperfusion Injury in Patients Undergoing Primary Percutaneous Coronary Intervention (PCI): The F.I.R.E.” Study - The F.I.R.E. Study

开始日期2006-07-10

申办/合作机构

FIBREX Medical, Inc.

100 项与 FIBREX Medical, Inc. 相关的临床结果

登录后查看更多信息

0 项与 FIBREX Medical, Inc. 相关的专利（医药）

登录后查看更多信息

1

项与 FIBREX Medical, Inc. 相关的文献（医药）

Drugs of the Future

FX06 (fibrin-derived peptide Bbeta15-42) - A potential candidate for myocardial reperfusion therapy

作者: Henning, Rainer ; Petzelbauer, Peter ; Zacharowski, Kai

A review.FX06 (fibrin derived peptide Bβ15-42) is a promising new drug candidate indicated for the prevention of reperfusion injury in patients undergoing primary percutaneous intervention (PCI) for acute myocardial infarction (AMI).This novel peptide has been shown to prevent myocardial reperfusion injury in a number of acute and chronic animal models for this disease when given as a single bolus injection at the time of reperfusion.FX06 has a novel mechanism of action: it is a competitive inhibitor of the binding of fibrin E1 fragments to vascular endothelial (VE)-cadherin.Through this inhibition, it potently blocks the transmigration of inflammatory leukocytes through the endothelial barrier and prevents the downstream release of tissue-damaging mediators.FX06 has proven safe in acute and subchronic toxicol. studies and recently entered clin. development.

100 项与 FIBREX Medical, Inc. 相关的药物交易

登录后查看更多信息

100 项与 FIBREX Medical, Inc. 相关的转化医学

登录后查看更多信息